Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjustable Lens (LAL) And The Light Delivery Device (LDD) To Improve Visual Outcomes

Exclusion Criteria

• •Study eye with zonular laxity or dehiscence.
• •Study eye with diabetes with any evidence of retinopathy.
• •Study eye with history of uveitis.
• •Subjects taking systemic medication that may increase sensitivity to UV light such as tetracycline, doxycycline, psoralens, amiodarone, phenothiazines, chloroquine, hydrochlorothiazide, hypericin, ketoprofen, piroxicam, lomefloxacin, and methoxsalen. LDD treatment in patients taking such medications may lead to irreversible phototoxic damage to the eye. This is only a partial list of photosensitizing medications. Please evaluate all medications that the patient is taking for this effect prior to consideration for implantation.
• •Subjects taking a systemic medication that is considered toxic to the retina such as tamoxifen.
• •Study eye with history of ocular herpes simplex virus.